The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Taiho Pharmaceutical
Stock and Other Ownership Interests - Abbvie; Otsuka; Takeda
Travel, Accommodations, Expenses - Taiho Pharmaceutical
Results of a phase II study evaluating trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite-stable (MSS) metastatic colorectal cancer (mCRC).
 
Manish R. Patel
Speakers' Bureau - Celgene; Exelixis; Genentech/Roche; Taiho Pharmaceutical
 
Gerald Steven Falchook
Employment - HealthONE; Sarah Cannon Research Institute
Research Funding - 3-V Biosciences; Abbvie; Aileron Therapeutics; ARMO BioSciences; AstraZeneca; BeiGene; Biothera; Celgene; Curegenix; Curis; DelMar Pharmaceuticals; eFFECTOR Therapeutics; EMD Serono; Fujifilm; Genmab; Hutchison MediPharma; Ignyta; Incyte; Jounce Therapeutics; Kolltan Pharmaceuticals; Lilly; Loxo; MedImmune; Merck; Millennium; Novartis; OncoMed; Precision Oncology; Regeneron; Rgenix; Strategia Therapeutics; Syndax; Taiho Pharmaceutical; Takeda; Tarveda Therapeutics; Tarveda Therapeutics; Tesaro; Tocagen; Vegenics
Patents, Royalties, Other Intellectual Property - Handbook of Targeted Cancer Therapy
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EMD Serono; Millennium; Sarah Cannon Research Institute
 
Kensuke Hamada
No Relationships to Disclose
 
Lukas Makris
Employment - Stathmi
Consulting or Advisory Role - Multiple pharmaceutical/biotech companies
 
Robert E. Winkler
Employment - Taiho Pharmaceutical
Travel, Accommodations, Expenses - Taiho Pharmaceutical
 
Gilad Shalag Gordon
Employment - Orra Group
Leadership - Orra Group; TEQ Analytic Laboratories
Stock and Other Ownership Interests - amidebio; TEQ Analytic Laboratories
Consulting or Advisory Role - Agios; Bayer; Clinipace; Deciphera; Fluidigm; Globavir; HERON; igm; miRagen; Pre-Cell; Prevacept; Taiho Pharmaceutical
Patents, Royalties, Other Intellectual Property - milestone payments on dengue vaccine development from Takeda
Travel, Accommodations, Expenses - Orra Group
 
Johanna C. Bendell
Research Funding - Abbott/AbbVie (Inst); ADC Therapeutics (Inst); Agios (Inst); Apexigen (Inst); Arch Oncology (Inst); ARMO BioSciences (Inst); Array BioPharma (Inst); Arrys Therapeutics (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celldex (Inst); cyteir (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); eFFECTOR Therapeutics (Inst); Eisai (Inst); EMD Serono (Inst); EMD Serono (Inst); Evelo Therapeutics (Inst); Five Prime Therapeutics (Inst); FORMA Therapeutics (Inst); Forty Seven (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Gritstone Bio (Inst); Harpoon therapeutics (Inst); Harpoon therapeutics (Inst); Incyte (Inst); Innate Pharma (Inst); Innate Pharma (Inst); Ipsen (Inst); Jacobio (Inst); Janssen (Inst); Kolltan Pharmaceuticals (Inst); Leap Therapeutics (Inst); Lilly (Inst); Macrogenics (Inst); Marshall Edwards (Inst); Merck (Inst); Merrimack (Inst); Mersana (Inst); Merus (Inst); Molecular Partners (Inst); Nektar (Inst); Novartis (Inst); Novocure (Inst); Oncogenex (Inst); OncoMed (Inst); Onyx (Inst); Phoenix Biotech (Inst); Pieris Pharmaceuticals (Inst); Prelude Therapeutics (Inst); Sanofi (Inst); Sierra Oncology (Inst); Sorrento Therapeutics (Inst); Stem CentRx (Inst); SynDevRx (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tarveda Therapeutics (Inst); TG Therapeutics (Inst); Tizona Therapeutics, Inc. (Inst); Torque (Inst); TRACON Pharma (Inst); Tyrogenex (Inst); Unum Therapeutics (Inst); Vyriad (Inst)
Travel, Accommodations, Expenses - Celgene; Daiichi Sankyo; Merck; Roche/Genentech